UK’s SAG-CS publishes Final Opinion on Methyl Salicylate as used in cosmetic products
Ingredients: Methyl Salicylate

Date of publication: 08/03/2024

On 8 March 2024, the UK SAG-CS published its Final Opinion on Methyl Salicylate as used in various cosmetic product types and age groups.

BACKGROUND

The UK Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) is the independent scientific advisory body to the UK cosmetics regulator, the Office for Product Safety & Standards (OPSS).  SAG-CS opinions form the basis for changes to the UK Cosmetics Regulation Annexes for ingredient restrictions. 

Methyl Salicylate (CAS No. 119-36-8, EC No. 204-317-7) is a cosmetic ingredient that is frequently part of fragrances used in cosmetic products. It is also used as a flavoring or soothing agent in oral care products. It may be found in hair products, bathing products, perfumery, make-up, and oral hygiene products, amongst others.

The safety of Methyl Salicylate has been evaluated by the EU Scientific Committee on Consumer Safety (SCCS), initially in 2021 and again in 2023, following revised concentrations submitted by industry to support safe use for children.

Methyl Salicylate is not currently listed in the Annexes of the Cosmetic Products Regulation UK (as amended). Under the GB Classification, Labelling and Packaging (CLP) Regulation No 1272/2008 (as amended), Methyl Salicylate has recently been classified as a category 2 reproductive toxicant (suspected of damaging the unborn child), as well as in acute toxicity category 4 and skin sensitiser category 1B.

Article 15 of the UK Cosmetics Regulation prohibits the use of category 1A, 1B and 2 Carcinogenic, Mutagenic or Reprotoxic (CMR) classified substances in cosmetic products under the GB CLP Regulation, unless an exemption has been granted by the Secretary of State following a positive opinion of the SAG-CS.

To obtain an exemption and ensure the continued use of Methyl Salicylate in cosmetic products, the UK Cosmetics Industry have provided a dossier of information and original studies to OPSS, aiming to support the safe use of methyl salicylate in the products listed in the following table:

WHAT’S NEW?

On 8 March 2024, the SAG-CS published its final opinion on Methyl Salicylate as used in cosmetics, establishing specific concentration limits for various product types and age groups.

Infants and Toddlers aged 0-3 years: maximum concentration of 0.015% in all dermally apllied products or 2.5% in toothpaste. Hydroalcoholic-based fragrances, face-make up products, eye make-up products and make-up remover, mouthwash and mouth spray have been excluded from the safety assessment for this age group.

Children aged 3-10 years: the current maximum concentrations as in the table above, except in mouthwash where the maximum concentration should be 0.1% (this is a difference when comparing with the EU SCCS opinion). Products not intended for or habitually used by children were excluded, e.g., mouthwash, hydroalcoholic-based fragrances, make-up and deodorant.

Adolescents (10-14 years): the current maximum concentrations as in the table above, except for mouthwash where the maximum concentration of Methyl Salicylate is reduced to 0.4% (this is a difference when comparing with the EU SCCS opinion).

Adults: SAG-CS considered Methyl Salicylate as acceptable for use by adults at the concentrations stated in the table above, even when considering an aggregate of all the product types and exposure routes (dermal, oral and inhalation).

References:

Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products (SAG-CS) – Final Opinion on Methyl Salicylate in Cosmetic Products, 2024.

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »
Any REGULATORY QUESTION?